Biography

Mark Drazner, M.D., brings nearly 20 years of advanced training and experience to bear on treating patients with cardiomyopathy and advanced heart failure, including those who undergo a heart transplant or implantation of a ventricular assist device to help a weakened heart pump blood. He currently is Medical Director of the Heart Failure, Left Ventricular Assist Devices (LVADs), and Cardiac Transplant Program at UT Southwestern. In June 2016 he also assumed the role of Clinical Chief of Cardiology.

Dr. Drazner has been at the forefront of research in the arena of heart failure and cardiac transplantation and was one of the first physicians in North Texas to be certified by the American Board of Internal Medicine in the new subspecialty of Advanced Heart Failure and Transplant Cardiology.

He received his initial medical training at Washington University in St. Louis, followed by residency in internal medicine at UT Southwestern, where he was Chief Resident. He then completed fellowships in cardiology at Duke University, and in heart failure/cardiac transplantation at Brigham and Women’s Hospital, the teaching affiliate of Harvard Medical School. Dr. Drazner also received a Master of Science in Epidemiology degree from Harvard University School of Public Health.

He is a member of the American Heart Association and the American College of Cardiology, among other professional organizations.

 

Education

Medical School
Washington University School of Medicine (1989)
Internship
UT Southwestern Medical Center (1990), Internal Medicine
Residency
UT Southwestern Medical Center (1992), Internal Medicine
Chief Resident
UT Southwestern Medical School (1993), Internal Medicine
Fellowship
Duke University School of Medicine (1996), Cardiology
Fellowship
Harvard Medical School/Brigham & Women's Hospital (1997), Congestive Heart Failure/cardiac Transplant
Graduate School
Harvard University School of Public Health (2001), Epidemiology

Research Interest

  • Advanced Heart Failure
  • Cardiac Transplantation
  • Left ventricular Hypertrophy

Publications

Featured Publications LegendFeatured Publications

Induction therapy with Basiliximab allows delayed initiation of Cyclosporine and preserves renal function following cardiac
Rosenberg, PB, Vriesendorp, AE, Drazner, MH, Dries, DL, Kaiser, PA, Hynan, LH, DiMaio, JM, Meyer, D, Ring, WS, Yancy, CW. J Heart Lung Transplant 2005 24 1327-1331

Honors & Awards

  • Best Doctors in America
    (2011)
  • D Magazine, Best Doctors (Cardiology)
    (2011)
  • Texas Super Doctors
    (2011)
  • D Magazine, Best Doctors (Cardiology)
    (2010)
  • Texas Super Doctors
    (2010)
  • Best Doctors in America
    (2009)
  • Texas Super Doctors
    (2009)
  • Texas Super Doctors
    (2008)
  • Best Doctors in America
    (2007)
  • Best Doctors in America
    (2005)
  • Best Doctors in America
    (2003)
  • AOA
    (1989)

Professional Associations/Affiliations

  • American College of Cardiology
  • American Heart Association
  • Heart Failure Society of America
  • International Society of Heart and Lung Transplantation